To address these shortcomings, we introduce SymPcNSGA-Testing (Symbolic execution, Path clustering and NSGA-II Testing), a ...
After 30 months of fast-paced innovation in quantum algorithms, six research groups are hoping to hit paydirt. But there can ...
The expansion enables Previvor Edge clinicians to rapidly translate complex genetic, medical, family history, and lifestyle risk data into a comprehensive Cancer Risk Profile and ...
Funding will expand the range of Dualase(R) genome editors for new high morbidity and mortality genetic disease targets. TORONTO, March 18, 2026 /PRNewswire/ - Specific Biologics Inc. ("Specific"), a ...
In a bid to better understand, and potentially treat, a host of conditions that affect early cognition, neurodevelopment, and ...
Metabolic-associated steatotic liver disease (MASLD) is a clinically heterogeneous condition with highly variable outcomes affecting more than 30% ...
Specific Biologics Inc. ("Specific"), a biotechnology company developing industry-leading in vivo genome editing medicines to treat the untreatable, today announced that together with Western ...
How can cells be programmed to respond to complex signals and make targeted decisions, similar to a logical circuit in a computer? Researchers have developed a new approach: an RNA-based genetic ...
India has launched its first repository of data on major psychiatric disorders, CALM-Brain, in Bengaluru. This initiative ...
Attachment to smart devices and biometric surveillance leaves Americans more vulnerable to police searches than ever. Left ...
For all the dreaming, computers cannot be humans, who are born and are made of mush and water and have to go to the bathroom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results